Containers and Packaging

GAPACK

GAPACK released FY2025 Q1 earnings on April 22 (BJT), actual revenue HKD 444.66 M, actual EPS HKD 0

GAPACK released FY2026 Q1 earnings on April 22 (BJT), actual revenue HKD 449.86 M, actual EPS HKD -0.0057

Fenmei Packaging's 2025 Annual Report Reveals Significant Decline in Revenue and Profit

GAPACK released FY2025 Semi-Annual earnings on April 21 After-Market (BJT), actual revenue HKD 1.09 B, actual EPS HKD 0.0637

GAPACK released FY2024 Annual Earnings on April 21 After-Market (BJT), actual revenue HKD 2.425 B (forecast HKD 3.96 B), actual EPS HKD 0.2103 (forecast HKD 0.196)

GAPACK released FY2025 Q4 earnings on April 21 After-Market (BJT), actual revenue HKD 497.56 M, actual EPS HKD -0.0191

GAPACK released FY2024 Q4 earnings on April 21 After-Market (BJT), actual revenue HKD 682.16 M, actual EPS HKD 0.0618

GAPACK released FY2025 annual earnings on April 21 After-Market (BJT), actual revenue HKD 2.03 B (forecast HKD 4.507 B), actual EPS HKD 0.0437 (forecast HKD 0.2128)

GAPACK to Release FY2025 Earnings on March 18 After-Market (BJT), Forecast Revenue HKD 4.507 B, EPS HKD 0.2128

GAPACK released FY2024 Q3 earnings on October 27, 2025 (BJT) with actual revenue of HKD 0 and EPS of HKD 0

GAPACK released FY2024 9 Months Earnings on October 27, 2025 (BJT) with actual revenue of HKD 1.104 B and EPS of HKD 0.0962

Funimark Announces 2024 Annual Earnings Forecast

GAPACK to Release FY2025 Semi-Annual Earnings on August 22, 2025 (BJT)

GAPACK to Release FY2024 Earnings on August 18 After-Market (BJT), Forecast Revenue HKD 3.96 B, EPS HKD 0.196

Fumin Packaging Removes Mr. Bi Hua as Executive Director

Fenmei Packaging Delays Release of 2024 Annual Performance

Fen Mei Packaging Adjusts Management Team

Fenmei Packaging Board Member Removals and Appointments Announcement

Fumei Packaging expects to fail to publish the 2024 annual performance report by March 31, 2025, as required by listing rules

Funmei Packaging Announces Acquisition Offer, Acceptance Rate of 66.55%

CH DEMETER FIN

FAMEGLOW

LUEN THAI

NEW GONOW RV

REF HOLDINGS

PARADISE ENT

WEBX HOLDING

HAICHANG HLDG

BEST FOOD HLDG

INTELLIMARK W27

00468

Greatview Aseptic Packaging Company Limited has completed the second-stage investigation related to a prior restructuring, addressing outstanding issues from the first stage. Despite this, the company's shares remain suspended from trading, creating uncertainty for shareholders and potential investors. Greatview specializes in aseptic packaging solutions for the beverage and liquid food industry and has a market cap of HK$3.52 billion.

Tip Ranks

Greatview Aseptic Completes Second-Stage Probe as Trading Suspension Continues

Greatview Aseptic Packaging Company Limited has proposed a final ordinary dividend of HKD 0.006 per share for the financial year ending 31 December 2025, pending shareholder approval on 23 June 2026. The ex-dividend date is set for 30 June 2026, with payment scheduled for 6 August 2026. This announcement reflects the company's commitment to shareholder returns and stable governance, as confirmed by the current board composition. Greatview specializes in aseptic packaging solutions for the food and beverage industry and is listed in Hong Kong under stock code 00468.

Greatview Aseptic Packaging Proposes Final Dividend for 2025

Greatview Aseptic Packaging Company reported a quarterly loss of RMB7.7 million for the three months ending March 31, 2026, down from a profit of RMB43.1 million a year earlier. Revenue decreased to RMB396.8 million from RMB415.2 million, impacted by rising administrative costs and reduced income. The company aims to keep shareholders informed while its shares are suspended on the Hong Kong Stock Exchange, highlighting challenges in profitability despite stable sales. Current market cap stands at HK$3.52 billion.

Greatview Swings to Quarterly Loss as Costs Rise Amid Ongoing Trading Suspension

Greatview Aseptic Packaging Company has announced its audited annual results for the year ended December 31, 2024, fulfilling Hong Kong listing requirements. However, its shares remain suspended from trading since February 19, 2025, leaving investors uncertain about liquidity. The board composition remains unchanged, indicating stable corporate governance during the suspension. This ongoing trading halt may impact shareholder confidence and the company's market visibility and access to capital. Greatview specializes in aseptic packaging solutions for the beverage and liquid food industry, with a market cap of HK$3.52B.

Greatview Aseptic posts 2024 results as trading suspension on HKEX continues

Greatview Aseptic Packaging Company (HK:0468) has released findings from an independent internal control review, a requirement for resuming trading on the Hong Kong Stock Exchange. Conducted by BT Corporate Governance Limited, the review assessed the adequacy of internal controls across various financial and operational processes, covering the period from January 1, 2025, to January 31, 2026. A follow-up review is scheduled for February 2026 to evaluate implemented remedial measures, indicating the company's commitment to addressing issues raised by shareholder investigations and moving towards trading resumption.

Greatview Outlines Internal Control Review Findings Amid Ongoing Trading Suspension

Greatview Aseptic Packaging Company has announced a further delay in publishing its 2024 annual results and 2025 reports due to extended audit requirements. The board meeting to approve these financials has been postponed to 21 April 2026, with reports expected by 30 April 2026. The company's shares have been suspended from trading since 19 February 2025, creating uncertainty for investors amid ongoing regulatory and operational pressures.

Greatview Aseptic Further Delays Results as Trading Suspension Continues

GAPACK's wholly-owned subsidiary has applied for arbitration with the Shanghai International Economic and Trade Arbitration Commission, claiming approximately RMB 75.6 million. The arbitration involves the entrusted production framework agreement with Yingte Packaging (Beijing) Co., Ltd. and the trademark licensing agreement with Wintipak AG. The company's shares will be suspended from trading starting February 19, 2025, until further notice

AASTOCKS

GAPACK's subsidiary initiates arbitration, claiming approximately 75.6 million RMB

Greatview Aseptic Units Launch SHIAC Arbitrations Tied to Divested International Business

Greatview Aseptic Units Launch SHIAC Arbitrations Tied to Divested International Business

GAPACK announced a further delay in the publication of its full-year results for 2024, last year's interim results, and last year's full-year results. The company's shares have been suspended from trading since February 19, 2025, and will remain suspended until further notice

GAPACK extends last year's interim and full-year results

Greatview Aseptic Packaging Company (HK:0468) has provided an update on its efforts to resume trading on the Hong Kong Stock Exchange after a suspension due to restructuring and delayed financial reporting. The company completed a second-stage independent investigation into past transactions and is undergoing a comprehensive internal control review. These steps aim to strengthen governance and address regulatory concerns to restore market confidence among shareholders and potential investors.

Greatview Advances Probe and Control Overhaul in Bid to Resume Trading

GAPACK(00468.HK)

Greatview Aseptic Completes Second-Stage Probe as Trading Suspension Continues

Greatview Aseptic Packaging Proposes Final Dividend for 2025

Greatview Swings to Quarterly Loss as Costs Rise Amid Ongoing Trading Suspension

Greatview Aseptic posts 2024 results as trading suspension on HKEX continues

Greatview Outlines Internal Control Review Findings Amid Ongoing Trading Suspension

Greatview Aseptic Further Delays Results as Trading Suspension Continues

GAPACK's subsidiary initiates arbitration, claiming approximately 75.6 million RMB

Greatview Aseptic Units Launch SHIAC Arbitrations Tied to Divested International Business

GAPACK extends last year's interim and full-year results

Greatview Advances Probe and Control Overhaul in Bid to Resume Trading